Feasibility and Acceptability of a Telehealth Intervention Among Women With Perinatal Mental Health
Perinatal Depression, Perinatal Anxiety, Substance Use
About this trial
This is an interventional prevention trial for Perinatal Depression
Eligibility Criteria
Inclusion Criteria: Women 18 and older who, at the time of enrollment Have a viable pregnancy or who are up to 12 months postpartum, Read and understand English, and Have an access to electronic device with internet access. And who have at least one of the following risk factors for perinatal depression/anxiety: Have an Edinburgh Postnatal Depression Scale (EPDS) score of 9-20, History of depression or anxiety, Have experienced two or more significant life events that put them at risk for developing depression (measured on the screening questionnaire), Have an NIDA Quick Screen and answered "yes" with any choices, Have a total score of NIDA Modified ASSIST 0-26 (mild to moderate risk) and report the use of common substances (cannabis, prescription opioids, inhalants, prescribed stimulants, and sedatives or sleeping pills) based on NIDA-Modified ASSIST. Exclusion Criteria: Less than 18 years old Have an EPDS score > 20 Have a NIDA Modified ASSIST score > 26; Have a current diagnosis of a serious mental illness, such as psychosis, schizophrenia, bipolar disorder, severe depression, or suicidality Have a current diagnosis of substance use disorder; or Currently use street opioids, cocaine, methamphetamine, and/or hallucinogens based on NIDA-Modified ASSIST
Sites / Locations
Arms of the Study
Arm 1
Experimental
UPLIFT Telehealth Intervention
The telehealth group intervention will be delivered using Zoom. Participants will attend facilitated weekly, 1-hour sessions for 8 weeks. The sessions follow a standardized, manualized program based on cognitive-behavioral therapy (CBT) and mindfulness-based practice (MBP)-therapies widely accepted and used by mental health providers for the treatment and prevention of depression and substance use. The study team have tailored this intervention for use in a pregnant population.